Kanagawa, Japan

Nobuyuki Nakata


Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1994-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Nobuyuki Nakata

Introduction

Nobuyuki Nakata is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 2 patents, Nakata's work focuses on compounds that have valuable applications in medical preparations.

Latest Patents

Nakata's latest patents include a Tetrahydroisoquinoline derivative and a medical preparation containing N-(3-pyridylalkyl)sulfonamide compounds. These compounds are particularly useful as thromboxane A2 production inhibitors, thromboxane A2 antagonists, prostaglandin H2 antagonists, anti-thrombus agents, thrombus-preventing agents, and anti-allergy agents. The derivatives he has developed are represented by specific formulae that illustrate their potential applications in the pharmaceutical industry.

Career Highlights

Nakata is associated with Terumo Kabushiki Kaisha, a company known for its advancements in medical technology. His work at Terumo has allowed him to focus on developing innovative solutions that address critical health issues. His contributions have been instrumental in enhancing the effectiveness of medical treatments.

Collaborations

Nakata has collaborated with notable coworkers, including Hiromasa Kohama and Masahiro Suzuki. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in their projects.

Conclusion

Nobuyuki Nakata's contributions to the field of pharmaceuticals through his patents demonstrate his commitment to innovation and improving medical treatments. His work continues to have a significant impact on the industry, showcasing the importance of research and development in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…